Neonatal jaundice from ghai

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
I now have all the content needed. Let me compile a comprehensive, well-structured answer on neonatal jaundice as covered in standard pediatric textbooks (equivalent to Ghai's approach).

Neonatal Jaundice

Note: Ghai's Essential Pediatrics is not available in this library. The following is a comprehensive, standard-curriculum-level coverage drawn from Rosen's Emergency Medicine and The Harriet Lane Handbook (Johns Hopkins), which cover neonatal jaundice in the same depth and framework as Ghai.

Pathophysiology

Bilirubin is formed from the breakdown of heme-containing proteins, primarily hemoglobin. Unconjugated (indirect) bilirubin binds to albumin, is carried to the liver, and is conjugated by UDP-glucuronyl transferase, then excreted into bile.
Three physiologic factors contribute to neonatal jaundice:
  1. Increased bilirubin production (higher RBC mass, shorter RBC lifespan ~70–90 days vs 120 days in adults)
  2. Decreased hepatic clearance and excretion (immature glucuronyl transferase)
  3. Increased enterohepatic resorption (gut flora immature, beta-glucuronidase deconjugates bilirubin back)
Jaundice becomes visible clinically when total bilirubin rises above ~5 mg/dL. Nearly every newborn develops unconjugated bilirubin >1 mg/dL (the adult upper limit) during the first week of life.

Classification

Unconjugated (Indirect) Hyperbilirubinemia

CategoryCause
Benign/physiologicPhysiologic jaundice, breast milk jaundice
HemolyticABO incompatibility, Rh incompatibility, G6PD deficiency, spherocytosis, elliptocytosis, sickle cell, thalassemia, pyruvate kinase deficiency
Birth traumaCephalhematoma reabsorption, IVH/ICH
InfectiousTORCHS, UTI, sepsis
Obstructive (enterohepatic)Meconium ileus, Hirschsprung, pyloric stenosis, duodenal atresia
Metabolic/geneticGalactosemia, hypothyroidism, Crigler-Najjar syndrome, Gilbert syndrome
MiscellaneousDehydration, polycythemia, drugs, hypoalbuminemia, panhypopituitarism

Conjugated (Direct) Hyperbilirubinemia

Always pathologic. Direct bilirubin >2.0 mg/dL and >10% of total serum bilirubin.
CategoryCause
Biliary obstructionBiliary atresia, choledochal cyst, inspissated bile syndrome, Alagille syndrome
InfectiousCMV, hepatitis B, HSV, rubella, toxoplasmosis, gram-negative sepsis, UTI
Metabolic/geneticα1-antitrypsin deficiency, galactosemia, tyrosinemia, glycogen storage disease, cystic fibrosis, Dubin-Johnson/Rotor syndrome, Niemann-Pick, Gaucher, Wilson disease
ChromosomalTrisomy 18, trisomy 21, Turner syndrome
Drugs/toxinsParenteral nutrition, acetaminophen, erythromycin

Types in Detail

1. Physiologic Jaundice

  • Occurs in ~50% of normal newborns
  • Due to immature bilirubin metabolism
  • Appears after 24 hours of life
  • TSB peaks at 6–8 mg/dL on days 2–4 in term infants (up to 12 mg/dL in some)
  • Resolves by 2 weeks in term infants (up to 3 weeks in preterm)
  • During first 3–4 days: TSB increases to 6.5 ± 2.5 mg/dL; max normal rise rate = 5 mg/dL/24 h or 0.2 mg/dL/h

2. Breast Milk Jaundice

  • Second most common cause of neonatal jaundice
  • Pathophysiology uncertain — possibly hormonally mediated or increased enterohepatic resorption
  • Peaks later (~10–21 days), may persist 3–10 weeks
  • Mild unconjugated hyperbilirubinemia; infant otherwise well
  • Treatment: temporary cessation of breastfeeding confirms diagnosis; usually not necessary

3. Pathologic Jaundice — Red Flags

Any jaundice is pathologic if:
  • Appears within 24 hours of birth
  • TSB rises >5 mg/dL/24 hr
  • TSB exceeds exchange transfusion threshold
  • Persists beyond 3 weeks of age
  • Associated with direct/conjugated hyperbilirubinemia
  • Infant appears sick

Risk Factors for Severe Hyperbilirubinemia

  • Birth weight <2500 g / prematurity
  • Exclusive breastfeeding
  • ABO or Rh incompatibility
  • Cephalhematoma or significant bruising
  • Predischarge TSB in high-risk zone
  • G6PD deficiency
  • Previous sibling requiring phototherapy
  • Low albumin, sepsis, acidosis
  • Infant of diabetic mother

Neurotoxicity: BIND and Kernicterus

Unconjugated bilirubin crosses the blood-brain barrier, causing neuronal death. At levels >20–25 mg/dL, risk of bilirubin-induced neurologic dysfunction (BIND) increases.

Acute Bilirubin Encephalopathy (ABE)

Early (potentially reversible):
  • Somnolence, poor feeding, hypotonia/hypertonia, high-pitched cry
Late (may be irreversible):
  • Lethargy, hypertonia, retrocollis, opisthotonos, fever, irritability, apnea → seizures → death

Kernicterus

Chronic, irreversible sequelae: cerebral palsy, sensorineural hearing loss, upward gaze palsy, intellectual disability.

Evaluation

TestIndication
Transcutaneous bilirubinometryQuick screen in well infants >24h and <7 days old
Total + fractionated serum bilirubinConfirmation and type (conjugated vs unconjugated)
CBC + peripheral smearHemolysis, infection
Direct Coombs testIsoimmune hemolysis (ABO/Rh)
Blood group (mother + infant)ABO/Rh incompatibility
Reticulocyte countHemolysis
G6PD assayIf risk factors present
Blood glucose, electrolytes, urine reducing substances, ammonia, lactateIll-appearing infant (IEM workup)
Urine cultureConjugated jaundice — exclude UTI
Liver ultrasoundConjugated jaundice — biliary atresia
Indications for evaluation of a jaundiced infant (Box 166.1):
  • Jaundice within first 24 hours
  • Elevated direct bilirubin
  • Rapidly rising TSB unexplained by history
  • TSB approaching exchange level or not responding to phototherapy
  • Jaundice persisting beyond 3 weeks
  • Sick-appearing infant

Management

General Principle

Goal: prevent BIND and kernicterus. Encourage feeding (including breastfeeding) — stimulates gut motility, reduces enterohepatic recirculation.

Phototherapy

Mechanism: Blue-spectrum light (wavelength ~460 nm) converts unconjugated bilirubin in the skin to water-soluble photoisomers (lumirubin) excreted in bile/urine without conjugation.
Intensive phototherapy should achieve a TSB decline of 1–2 mg/dL within 4–6 hours.
Guidelines for term infants (≥35 weeks) — AAP:
Phototherapy Guidelines — AAP (Rosen's Emergency Medicine)
Guidelines for preterm infants (<35 weeks, Harriet Lane):
Gestational AgePhototherapy ThresholdConsider Exchange Transfusion
<28 weeks5–6 mg/dL11–14 mg/dL
28–29 6/7 weeks6–8 mg/dL12–14 mg/dL
30–31 6/7 weeks8–10 mg/dL13–16 mg/dL
32–33 6/7 weeks10–12 mg/dL15–18 mg/dL
Risk factors that lower threshold: isoimmune hemolytic disease, G6PD deficiency, asphyxia, significant lethargy, temperature instability, sepsis, acidosis, albumin <3.0 g/dL.

Exchange Transfusion (Double-Volume)

Used when phototherapy fails or TSB reaches dangerous levels.
Indications:
  • TSB continues to rise or remains above exchange threshold despite intensive phototherapy
  • Signs of acute bilirubin encephalopathy (hypertonia, retrocollis, opisthotonos, fever, high-pitched cry) — immediate exchange transfusion
  • TSB ≥5 mg/dL above the exchange line
Guidelines for ≥35 weeks gestation:
Exchange Transfusion Guidelines — AAP (Rosen's Emergency Medicine)
Procedure: Double-volume exchange (160–200 mL/kg) removes ~85% of sensitized RBCs and bilirubin-laden blood, replacing it with donor blood.

IVIG (for Isoimmune Hemolytic Disease)

  • Dose: 0.5–1 g/kg IV over 2 hours
  • Indicated if TSB is rising despite intensive phototherapy, or TSB is within 2–3 mg/dL of exchange transfusion threshold

Conjugated Hyperbilirubinemia Management

  • Depends on underlying etiology
  • Ursodiol for infants on full feeds
  • Fat-soluble vitamin supplementation (A, D, E, K)
  • Phototherapy is not contraindicated but risk of "bronze baby" syndrome (transient dark gray-brown discoloration of skin, serum, urine) must be weighed
  • Biliary atresia: surgical referral (Kasai portoenterostomy) — time-sensitive

Summary Table: Physiologic vs Pathologic Jaundice

FeaturePhysiologicPathologic
OnsetAfter 24 hoursWithin 24 hours
Peak TSB (term)≤12 mg/dL>12 mg/dL
Rise rate<5 mg/dL/day>5 mg/dL/day
Duration<2 weeks (term)>3 weeks
Bilirubin typeUnconjugatedMay be conjugated
General conditionWell infantMay be sick

Sources: Rosen's Emergency Medicine, 9th Ed., Ch. 166; The Harriet Lane Handbook, 23rd Ed., Ch. 18 — Harriet Lane Handbook (Johns Hopkins)
This is a shared conversation. Sign in to Orris to start your own chat.